Here’s what you should know.
Mr. Saunders said the company aligned with the “priorities of the incoming Trump administration.”
He added the company intends to create more jobs in the United States to fuel the economy.
More articles on gastroenterology/endoscopy:
Exact Sciences, Takeda Pharmaceuticals & more — 6 GI company key notes
GI leader to know: Dr. Deborah Blalock of Blalock GI Care
How investors reacted to Valeant’s $2.1B sell off: 4 key insights
